Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design
Kathleen W. Beekman, A. Dimitrios Colevas, Kathleen Cooney, Robert DiPaola, Rodney L. Dunn, Mitchell Gross, Evan T. Keller, Kenneth J. Pienta, Charles J. Ryan, David Smith, Maha Hussain
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design'. Together they form a unique fingerprint.